PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
22-Jan-2025 Relief Therapeutics Completes Strategic Transition with Sale of GOLIKE Rights ex-US Relief Therapeutics Holding SA
21-Jan-2025 Catalent Announces Collaboration with Galapagos to Further Expand Galapagos’ Decentralized CAR-T Manufacturing Network in the U.S. Catalent
21-Jan-2025 ACG to Showcase Sustainable Packaging Innovations at Pharmapack Paris 2025 -Welcomes Jochen Scheil as Head of Global Sales for ACG Packaging Materials- ACG
21-Jan-2025 MEDICLIN raises full-year guidance for the 2024 financial year MEDICLIN AG
21-Jan-2025 PM Society Announces Updates to Training Programme PM Society
21-Jan-2025 Mainz Biomed Initiates U.S. Clinical Study to Evaluate Performance of Next Generation Test on Advanced Adenomas over Large Patient Population Mainz BioMed N.V.
21-Jan-2025 Terumo Blood and Cell Technologies Highlights the Future of Blood in DAVOS Interviews 2025 Film Series Terumo Blood and Cell Technologies
21-Jan-2025 Uniphar appoints industry leader, Isaac Batley, as Global Head of Scientific Communications Uniphar
21-Jan-2025 European Commission approves LAZCLUZE®▼ (lazertinib) in combination with RYBREVANT®▼ (amivantamab) for the first-line treatment of patients with EGFR-mutated advanced non-small cell lung cancer Janssen-Cilag International NV
21-Jan-2025 Cambridge Cognition expands services with the launch of in-house Rater Training Cambridge Cognition
21-Jan-2025 Opella reaches study milestone for Cialis Sanofi
21-Jan-2025 DocMorris grows 6.7 per cent in 2024 and accelerates Rx growth in the fourth quarter DocMorris AG
20-Jan-2025 PM Society Awards 2025 - Tickets Now on Sale! PM Society
20-Jan-2025 Public to question MPs on the use of evidence in Parliament at ‘reverse’ Select Committee hearing Sense about Science
20-Jan-2025 European Commission expands Jemperli (dostarlimab) plus chemotherapy approval to all adult patients with primary advanced or recurrent endometrial cancer GSK
20-Jan-2025 Marinomed Biotech AG: Restructuring proceedings successfully completed Marinomed Biotech AG
20-Jan-2025 Formycon receives EU approval for FYB203 (aflibercept), a biosimilar to Eylea®, under the brand names AHZANTIVE® and Baiama® Formycon AG
15-Jan-2025 Drägerwerk AG & Co. KGaA: Preliminary figures 2024: Net sales just below and earnings just above expectations – Forecast 2025 Drägerwerk AG & Co. KGaA
15-Jan-2025 Vetter Introduces the Next Evolution of the V-OVS® Syringe Closure System Vetter
15-Jan-2025 Santhera Receives Positive Recommendation from Scottish Medicines Consortium for the Use of AGAMREE® (Vamorolone) in Duchenne Muscular Dystrophy Patients in NHS Scotland Santhera